3 unknown, 1 completed. 3 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Unknown 2, Completed 1 |
| Phase 2 | 3 | Unknown 3 |
Follow Triple-Negative Invasive Breast Carcinoma: new trials by email Literature Review of Triple-Negative Invasive Breast Carcinoma trials Research Report on Triple-Negative Invasive Breast Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Autologous Hematopoietic Stem Cell Transplantation as Adjuvant Treatment for Triple Negative Breast Cancer Patients Carmustine, Cyclophosphamide, Carboplatin - Triple-Negative Invasive Breast Carcinoma, Residual Tumor | Phase 2 | Unknown | Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | 20 | 2018-02-01 | 2020-01-14 |
| CAR-pNK Cell Immunotherapy in MUC1 Positive Relapsed or Refractory Solid Tumor anti-MUC1 CAR-pNK cells - Hepatocellular Carcinoma, Non-small Cell Lung Cancer | Phase 1 / Phase 2 | Unknown | PersonGen BioTherapeutics (Suzhou) Co., Ltd. | 10 | 2016-07-01 | 2016-12-06 |
| Phase I/II Study of Anti-Mucin1 (MUC1) CAR T Cells for Patients With MUC1+ Advanced Refractory Solid Tumor anti-MUC1 CAR T Cells - Hepatocellular Carcinoma, Non-small Cell Lung Cancer | Phase 1 / Phase 2 | Unknown | PersonGen BioTherapeutics (Suzhou) Co., Ltd. | 20 | 2015-10-01 | 2016-12-05 |
| Olaparib and Radiotherapy in Inoperable Breast Cancer radiotherapy, olaparib - Locally Advanced Malignant Neoplasm, Inflammatory Breast Carcinoma | Phase 1 | Completed | The Netherlands Cancer Institute | 7 | 2013-10-21 | 2021-08-04 |
Carcinoma, Hepatocellular (2) · Carcinoma, Non-Small-Cell Lung (2) · Pancreatic Neoplasms (2) · Breast Neoplasms (1) · Colorectal Neoplasms (1) · Inflammatory Breast Neoplasms (1) · Neoplasm, Residual (1) · Stomach Neoplasms (1)
Neoplasms (4) · Neoplasms by Site (3) · Adenocarcinoma (2) · Bronchial Neoplasms (2) · Carcinoma (2) · Carcinoma, Bronchogenic (2) · Digestive System Diseases (2) · Digestive System Neoplasms (2) · Endocrine Gland Neoplasms (2) · Endocrine System Diseases (2) · Liver Diseases (2) · Liver Neoplasms (2) · Lung Diseases (2) · Lung Neoplasms (2) · Neoplasms by Histologic Type (2)
Busulfan (1) · Carboplatin (1) · Carmustine (1) · Cyclophosphamide (1) · Radiotherapy (1) · Sensitivity and Specificity (1) · olaparib (1)
PersonGen BioTherapeutics (Suzhou) Co., Ltd. (2) · Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran (1) · The Netherlands Cancer Institute (1)
China (2) · Mexico (1) · Netherlands (1)
Lin Yang, Ph.D. (2) · Eucario Leon Rodriguez, M.D. (1) · Gabe Sonke, MD, PhD (1) · Monica M Rivera Franco, M.D.,MSc (1)